The effect of intravitreal injection of anti-VEGF drugs on the ophthalmotonus values in patients with classic and occult choroidal neovascularization
<br> Kuroyedov A.V.<sup>1,2</sup>, Zakharova M.A.<sup>3</sup>, Gaponko O.V.<sup>1</sup>, Gorodnichy V.V.<sup>1</sup><br> <br> <sup>1</sup> Central Military Clinical Hospital named after P. V. Mandryka, Moscow<br>...
Main Authors: | A.V. Kuroyedov, Zakharova M.A., O.V. Gapon’ko, V.V. Gorodnichiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2018-07-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/7b4/7b467e72ed1c1d901eaef66a83a5e862.pdf |
Similar Items
-
Effectiveness and tolerability of the combined use of anti-VEGF agents in clinical practice
by: A.V. Kuroyedov, et al.
Published: (2020-11-01) -
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
by: T. Barth, et al.
Published: (2019-11-01) -
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012-05-01) -
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
by: Shih-Lin Chen, et al.
Published: (2021-09-01) -
Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)